Secondary osteoporosis in men and women: Clinical challenge of an unresolved issue

Journal of Rheumatology

Volumn 38, Issue 8, 2011, Pages 1671-1679

  Romagnoli, Elisabetta ^a   Del Fiacco, Romano ^a   Russo, Stefania ^a   Piemonte, Sara ^a   Fidanza, Francesca ^a   Colapietro, Francesca ^a   Diacinti, Daniele ^a   Cipriani, Cristiana ^a   Minisola, Salvatore ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Algorithm; Bone mineral density; Fracture; Gender; Osteoporosis

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITOMETRY; BONE DENSITY; CHEMICAL ANALYSIS; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FRACTURE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; PRACTICE GUIDELINE; PREVALENCE; PRIMARY OSTEOPOROSIS; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RADIODIAGNOSIS; RISK ASSESSMENT; RISK FACTOR; SECONDARY OSTEOPOROSIS; SEX RATIO; THORACIC SPINE;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BONE DENSITY; FEMALE; FRACTURES, BONE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 79961100482     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110030     Document Type: Article

References (42)

1. Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clin Proc 2002;77:453-68. (Pubitemid 34465153)
2. Guggenbuhl P. Osteoporosis in males and females: is there really a difference? Joint Bone Spine 2009;76:595-601.
3. Hofbauer LC, Hamann C, Ebeling PR. Approach to the patient with secondary osteoporosis. Eur J Endocrinol 2010;162:1009-20.
4. Odabasi E, Turan M, Tekbas F, Kutlu M. Evaluation of secondary causes that may lead to bone loss in women with osteoporosis: a retrospective study. Arch Gynecol Obstet 2009;279:863-7.
5. Tannenbaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D, et al. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 2002;87:4431-7. (Pubitemid 35247019)
6. Cerdá Gabaroi D, Peris P, Monegal A, Albaladejo C, Martínez MA, Muxí A, et al. Search for hidden secondary causes in postmenopausal women with osteoporosis. Menopause 2010;17:135-9.
7. Deutschmann HA, Weger M, Weger W, Kotanko P, Deutschmann MJ, Skrabal F. Search for occult secondary osteoporosis: impact of identified possible risk factors on bone mineral density. J Intern Med 2002;252:389-97. (Pubitemid 36706570)
8. Ryan CS, Petkov VI, Adler RA. Osteoporosis in men: the value of laboratory testing. Osteoporos Int 2010 Oct 9. (E-pub ahead of print)
9. Jamal SA, Leiter RE, Bayoumi AM, Bauer DC, Cummings SR. Clinical utility of laboratory testing in women with osteoporosis. Osteoporos Int 2005;16:534-40.
10. Briot K, Cortet B, Trémollières F, Sutter B, Thomas T, Roux C, et al. Male osteoporosis: diagnosis and fracture risk evaluation. Joint Bone Spine 2009;76:129-33.
11. Ebeling PR. Clinical practice. Osteoporosis in men. N Engl J Med 2008;358:1474-82.
12. Boonen S, Kaufman J, Goemaere S, Bouillon R, Vanderschueren D. The diagnosis and treatment of male osteoporosis: defining, assessing, and preventing skeletal fragility in men. Eur J Intern Med 2007;18:6-17. (Pubitemid 46072727)
13. Compston J, Cooper A, Cooper C, Francis R, Kanis JA, Marsh D, et al. Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas 2009;62:105-8.
14. Siris ES, Baim S, Nattiv A. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men. Postgrad Med 2010;122:82-90.
15. Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D'Erasmo E, et al. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab 2008;93:3015-20.
16. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993;8:1137-48. (Pubitemid 23261108)
17. Carnevale V, Romagnoli E, Cipriani C, Del Fiacco R, Piemonte S, Pepe J, et al. Sex hormones and bone health in males. Arch Biochem Biophys 2010;503:110-7.
18. Jaglal SB, McIsaac WJ, Hawker G, Carroll J, Jaakkimainen L, Cadarette SM, et al. Information needs in the management of osteoporosis in family practice: an illustration of the failure of the current guideline implementation process. Osteoporos Int 2003;14:672-6. (Pubitemid 41490352)
19. Laliberté M, Perreault S, Dragomir A, Goudreau J, Rodrigues I, Blais L, et al. Impact of a primary care physician workshop on osteoporosis medical practices. Osteoporos Int 2010;21:1471-85.
20. Cadarette SM, Gignac MAM, Jaglal SB, Beaton DE, Hawker GA. Access to osteoporosis treatment is critically linked to access to dual-energy x-ray absorptiometry testing. Med Care 2007;45:896-901.
21. Curtis JR, Adachi JD, Saag KG. Bridging the osteoporosis quality chasm. J Bone Min Res 2009;24:3-7.
22. Curtis JR, Carbone L, Cheng H, Hayes B, Laster A, Matthews R, et al. Longitudinal trends in use of bone mass measurement among older Americans, 1999-2005. J Bone Min Res 2008;23:1061-7. (Pubitemid 351915728)
23. Cheng N, Green ME. Osteoporosis screening for men: are family physicians following the guidelines? Can Fam Physician 2008;54:1140-1.
24. Curtis JR, McClure LA, Delzell E, Howard VJ, Orwoll E, Saag KG, et al. Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender. J Gen Intern Med 2009;24:956-62.
25. Sedlak CA, Doheny MO, Estok PJ, Zeller RA, Winchell J. DXA, health beliefs, and osteoporosis prevention behaviors. J Aging Health 2007;19:742-56. (Pubitemid 47373253)
26. Doheny MO, Sedlak CA, Hall RJ, Estok PJ. Structural model for osteoporosis preventing behavior in men. Am J Mens Health 2010;4:334-43.
27. Brask-Lindemann D, Cadarette SM, Eskildsen P, Abrahamsen B. Osteoporosis pharmacotherapy following bone densitometry: importance of patient beliefs and understanding of DXA results. Osteoporos Int 2010 Aug 4. (E-pub ahead of print)
28. Peris P, Martínez-Ferrer A, Monegal A, Martínez de Osaba MJ, Alvarez L, Ros I, et al. Aetiology and clinical characteristics of male osteoporosis. Have they changed in the last few years? Clin Exp Rheumatol 2008;26:582-8.
29. Trimpou P, Landing-Wilhelmsen K, Oden A, Rosengren A, Wilhelmsen L. Male risk factors for hip fracture - a 30 year follow-up study in 7,495 men. Osteoporos Int 2010;21:409-16.
30. McKiernan FE, Berg RL, Linneman JG. The utility of BMD Z-score diagnostic thresholds for secondary causes of osteoporosis. Osteoporos Int 2011;22:1069-77.
31. Mazziotti G, Canalis E, Giustina A. Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med 2010;123:877-84.
32. Kok C, Sambrook PN. Secondary osteoporosis in patients with an osteoporotic fracture. Best Pract Res Clin Rheumatol 2009;23:769-79.
33. Stenson WF, Newberry R, Lorenz R, Baldus C, Civitelli R. Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Arch Intern Med 2005;165:393-9. (Pubitemid 40280193)
34. Bandeira F, Griz LH, Bandeira C, Pinho J, Lucena CS, Alencar C, et al. Prevalence of cortical osteoporosis in mild and severe primary hyperparathyroidism and its relationship with bone markers and vitamin D status. J Clin Densitom 2009;12:195-9.
35. Sitges-Serra A, Garcia L, Prieto R, Pena MJ, Nogues X, Sancho JJ. Effect of parathyroidectomy for primary hyperparathyroidism on bone mineral density in postmenopausal women. Br J Surg 2010;97:1013-9.
36. Bilezikian JP, Khan AA, Potts JT. Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary Statement from the Third International Workshop. J Clin Endocrinol Metab 2009;94:335-9.
37. Audran M, Legrand E. Hypercalciuria. Joint Bone Spine 2000;67:509-15. (Pubitemid 32014786)
38. Chiodini I, Mascia ML, Muscarella S, Battista C, Minisola S, Arosio M, et al. Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann Intern Med 2007;147:541-8. (Pubitemid 351664501)
39. Adami S, Bertoldo F, Brandi ML, Cepollaro C, Filipponi P, Fiore E, et al. Guidelines for the diagnosis, prevention and treatment of osteoporosis. Reumatismo 2009;61:260-84.
40. Hamdy RC, Kiebzak GM. Variance in 10-year fracture risk calculated with and without T-scores in select subgroups of normal and osteoporotic patients. J Clin Densitom 2009;12:158-61.
41. Binkley N. A perspective on male osteoporosis. Best Pract Res Clin Rheumatol 2009;23:755-68.
42. Silverman SL, Calderon AD. The utility and limitations of FRAX: a US perspective. Curr Osteoporos Rep 2010;8:192-7.